Project Grant R21MH136489

Award Date 9/23/24
Completion Date 8/31/26
Dollars Obligated $251K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Plandome, NY 11030, USA
Similar Awards
This federal Project Grant award of $2,049,254.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research into the role of transient neuronal connectivity in healthy brain development and its implications for Fragile X Syndrome, a leading genetic cause of autism. The research aims to investigate the mechanisms by which sensory and neuromodulatory inputs establish transient connections with inhibitory neurons...
The National Institute of Mental Health (NIMH) awarded a $437,250 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of Pittsburgh to study the role of local interneurons in early cortical dysfunction in Shank3 knockout mice, a model of autism spectrum disorder (ASD). The grant will fund research using whole-cell electrophysiology and 2-photon microscopy to characterize the physiological properties of Shank3 knockout cortical parvalbumin and somatostatin-positive...
This Project Grant award of $194,375.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program aims to elucidate the impact of midbody remnant (MBR)-mediated genetic information transfer on cortical cellular composition in the context of an autism spectrum disorder (ASD)-linked PTEN mutation. The primary objectives are to: 1) Determine how the PTEN(+/-) mutation alters the molecular landscape of MBRs during neural differentiation, and...
This $194,940 Project Grant award from the National Institute of Mental Health (NIMH) Mental Health Research Grants program (CFDA 93.242) supports a four-year career development and research program led by Dr. Mo at Boston Children's Hospital. The primary objective is to study the role of somatic (post-zygotic) variants in autism spectrum disorder (ASD). Key activities include developing expertise in human genetics, next-generation sequencing data analysis, and interpretation of somatic...
This Project Grant award from the National Institute of Mental Health (NIMH) under CFDA Program 93.242 - Mental Health Research Grants provides $439,804 to support a research project led by Creighton University investigating the role of the KMT5B gene in regulating the insulin-like growth factor (IGF) system and its impact on neurodevelopmental phenotypes observed in autism spectrum disorder (ASD). The key objectives of the five-year project are to: 1) specify the role of KMT5B in paracrine...
The Feinstein Institutes for Medical Research received a $921,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a study from August 15, 2022 to August 14, 2025 to research microglia as potential therapeutic targets for Autism Spectrum Disorder (ASD) using a mouse model of maternal anti-Caspr2 antibody-induced ASD. The Military Medical Research and Development program supports...
This $258,620 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to uncover sex-specific differences in the genetics and neurobiology of psychiatric disorders. The primary awardee, Brown University, will conduct a high-risk, high-reward research program that combines clinical neurofenotyping and stem cell studies to define the mechanisms underlying sex-specific differences associated with...
This $367,708 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research on the neural underpinnings of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD). The University of Southern California (USC) will use cutting-edge functional MRI techniques and advanced machine learning methods to investigate how connectivity patterns in the brain's reward circuitry differ...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $834,894 to Yale University to examine connections between neonatal brain network characteristics and later social development outcomes in infants with and without a family history of autism. The research aims to identify early brain-based risk factors and potential targets for early interventions to support social attention and engagement skills...
This Project Grant award of $255,362 from the National Institute of Mental Health (NIMH), under CFDA Program 93.242 Mental Health Research Grants, supports research to understand neural mechanisms underlying reward processing differences in autistic adolescents compared to neurotypical youth. The key objectives are to: 1) isolate differences in neural response to social vs. non-social rewards using a novel fMRI-based feedback paradigm, 2) quantify differences in midbrain dopamine system...

This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $251,250 to The Feinstein Institutes for Medical Research to study sex-dependent dysregulation of parvalbumin interneurons as a pathway to autism spectrum disorder (ASD).

The research aims to examine whether in utero exposure to anti-CASPR2 antibodies has sex-specific epigenetic effects on the maturation of parvalbumin interneurons, which may contribute to neural network imbalances in male mice. Key activities include investigating epigenetic changes disrupting the transcriptional profile of parvalbumin interneurons, and characterizing the development of abnormal parvalbumin interneuron network patterns and their functional consequences. This work leverages the Feinstein Institutes' expertise in neuroscience, immunology, and translational research to advance the understanding of ASD pathophysiology. The award period runs from September 2024 through August 2026.

Generated 4/8/25, 3:08 AM